نتایج جستجو برای: pipobromane anticancer drug

تعداد نتایج: 613496  

M Mehrabi, S Rezaei-Zarchi, A Javid, A Hashemi,

Abstract Background Nanoparticulate drug delivery systems have attracted significant attention in the field of cancer nanotechnology. This study determines the effect of folate-based Fe2O3 nanoparticles. This study aimed to decorate nanoparticles with folate (FA), a molecular ligand for ‘active’ targeting of cancerous cells and the application of modified-nanoparticles in cancer treatment. ...

Introduction: For thousands of years, plants have been used as the main source of drug worldwide. Recently, it has been found out that the plant Artemisia annua and especially its derivatives such as artemether have anticancer properties. Methods: In this study, the anticancer effect of artemether on MCF-7 breast cancer cell line was examined. MTT assay was used to assess the viability of c...

Journal: :The Journal of pharmacology and experimental therapeutics 2006
Jayant J Khandare Pooja Chandna Yang Wang Vitaly P Pozharov Tamara Minko

We designed, synthesized, and evaluated in vitro and in vivo a novel targeted anticancer polymeric prodrug containing multiple copies of tumor targeting moiety [synthetic luteinizing hormone-releasing hormone (LHRH) peptide, analog of LHRH] and anticancer drug (camptothecin). One, two, or three molecules of the targeting peptide and anticancer drug were covalently conjugated with bis(2-carboxye...

2013
Hsin-chung Lee Qing-Dong Ling Wan-Chun Yu Chunh-Ming Hung Ta-Chun Kao Yi-Wei Huang Akon Higuchi

PURPOSE We evaluated the higher levels of carcinoembryonic antigen (CEA) secreted by the LoVo human colon carcinoma cells in a medium containing anticancer drugs. Drug-resistant LoVo cells were analyzed by subcutaneously xenotransplanting them into mice. The aim of this study was to evaluate whether the drug-resistant cells isolated in this study were cancer-initiating cells, known also as canc...

Journal: :The oncologist 2006
Irma Meijerman Jos H Beijnen Jan H M Schellens

An increasing number of cancer patients are using complementary and alternative medicines (CAM) in combination with their conventional chemotherapeutic treatment. Considering the narrow therapeutic window of oncolytic drugs, this CAM use increases the risk of clinically relevant herb-anticancer drug interactions. Such a relevant interaction is that of St. John's wort with the anticancer drugs i...

Journal: :Nature Reviews Drug Discovery 2018

Journal: :British Journal of Cancer 1996

Journal: :Advances in Pharmacology & Clinical Trials 2017

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید